Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company Name/Scheme Chimeric Therapeutics Limited ACN/ARSN 1. Details of substantial holder (1)Name Magellan Financial Group Ltd (MFG) and each of its related bodies corporate listed in Part A and Part...
Ceasing to be a substantial holder for CHM
Filed with ASX · · 4 pages · English
Release
Chimeric Therapeutics Limited on 6ix
Earlier from Chimeric Therapeutics
- Notice of initial substantial holder for CHM
- Final Director's Interest Notice - LR
- Final Director's Interest Notice - BG
- Initial Director's Interest Notice - RM
- FY2026 Annual Report, creditor update and Board changes
Later from Chimeric Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Notification of cessation of securities - CHM
Follow Chimeric Therapeutics into a list and get an email when it puts out news.
Follow Chimeric Therapeutics